Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhibition of Nuclear Factor Kappa B for Prevention of Disease Progression in Indolent B Cell Malignancies

NCT00899353 is registered in ClinicalTrials.gov with Marshall University as lead sponsor.

NCT NCT00899353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00899353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhibition of Nuclear Factor Kappa B for Prevention of Disease Progression in Indolent B Cell Malignancies
Lead sponsor
Marshall University
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2008
Completion date
October 31, 2012
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma